Market Tracker

09/19 6:35pm ET

Gilead Sciences Inc (NASDAQ:GILD)

105.96
Data as of Sep 19
 +0.03 / +0.03%
Today’s Change
58.81
Today|||52-Week Range
110.64
+41.09%
Year-to-Date

Today’s Trading

Previous close105.93
Today’s open107.75
Day’s range105.51 - 107.89
Volume22,238,409
Average volume (3 months)13,397,132
Market cap$160.2B
Dividend yield--
Data as of 4:14pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)+10.37%
Earnings growth (this year)+292.64%
Earnings growth (next 5 years)+18.05%
Revenue growth (last year)+16.72%
P/E ratio23.8
Price/Sales10.23
Price/Book14.30

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen Inc+1.99+1.40%
BIIBBiogen Idec Inc-0.75-0.23%
BAXBaxter International...-0.56-0.77%
ITMNInterMune Inc+0.15+0.20%
Data as of 4:14pm ET, 09/19/2014

Financials

Next reporting dateOctober 21, 2014
EPS forecast (this quarter)$1.90
Annual revenue (last year)$11.2B
Annual profit (last year)$3.1B
Net profit margin27.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts